Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,500
Closed -$7.61M 66
2025
Q2
$7.61M Sell
9,500
-17,800
-65% -$12.8M 0.18% 143
2025
Q1
$18.1M Buy
27,300
+6,000
+28% +$4.36M 0.46% 46
2024
Q4
$14.8M Buy
21,300
+5,900
+38% +$4.24M 1.06% 23
2024
Q3
$12.8M Buy
15,400
+5,500
+56% +$4.92M 0.36% 77
2024
Q2
$10.1M Buy
9,900
+1,200
+14% +$1.15M 0.36% 83
2024
Q1
$8.44M Buy
8,700
+5,300
+156% +$4.7M 0.36% 96
2023
Q4
$2.57M Sell
3,400
-2,700
-44% -$1.78M 0.22% 104
2023
Q3
$3.59M Buy
6,100
+2,500
+69% +$1.66M 0.17% 121
2023
Q2
$2.61M Buy
3,600
+1,000
+38% +$680K 0.15% 159
2023
Q1
$1.77M Buy
+2,600
New +$1.67M 0.09% 177

Other funds holding ASML

Garda Capital Partners's ASML Position: Q2 2025 in Review

Garda Capital Partners sold out of ASML (ASML) in Q2 2025, closing a stake of 8,353 shares — an estimated $5.99M sold.

Garda Capital Partners first reported a position in ASML in Q3 2023 and held it in 4 quarters. The position peaked at $5.53M in Q1 2025. 1,713 funds tracked by Wall St. Rank hold ASML as of Q2 2025.

  • Garda Capital Partners reported no remaining ASML position as of Q2 2025 after selling out during the quarter.
  • Garda Capital Partners sold 8,353 ASML shares in Q2 2025, an estimated $5.99M.
  • Garda Capital Partners first reported a position in ASML in Q3 2023 and held it in 4 quarters.
  • Garda Capital Partners's ASML position peaked at $5.53M in Q1 2025.
  • 1,713 funds tracked by Wall St. Rank held ASML as of Q2 2025.

Based on Garda Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.